Tri-Heal Max 45mg TB-500 25mg + BPC-157 10mg + KPV 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Tri-Heal Max supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF092025045

Key analytical results include:

• BPC-157 Assay Content: 12.70 mg
• BPC-157 Identification – Retention Time: 0.994
• KPV Assay Content: 13.19 mg
• KPV Identification – Retention Time: 0.984
• Thymosin Beta-4 (TB-500) Assay Content: 29.7 mg
• Thymosin Beta-4 (TB-500) Identification – Retention Time: 0.990
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Tri-Heal Max is a multi-peptide research formulation combining several peptides frequently studied in laboratory environments focused on cellular repair signalling and tissue regulatory pathways.

The formulation contains a combination of BPC-157, KPV and Thymosin Beta-4 (TB-500), peptides that are commonly investigated in experimental models examining cellular signalling and peptide-mediated regulatory systems.

This preparation contains a combined total of 45 mg of high purity lyophilized peptide compounds supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compounds for controlled in vitro experimentation.

Because of its defined peptide composition and stable analytical profile, Tri-Heal Max is frequently referenced in experimental peptide research models investigating cellular repair and signalling pathways.

Compound Overview

Tri-Heal Max contains a combination of three peptide compounds used in laboratory research environments:

• BPC-157 — a peptide fragment studied in experimental models investigating cellular signalling and regulatory pathways.
• KPV — a tripeptide derived from alpha-MSH fragments that has been investigated in research related to cellular signalling and peptide interaction pathways.
• Thymosin Beta-4 (TB-500) — a peptide associated with cytoskeletal protein regulation and cellular migration signalling processes.

These peptides are frequently explored individually and in combination within experimental models examining cellular regulatory mechanisms and peptide-mediated signalling networks.

Historical Background and Scientific Context

Scientific research into regulatory peptides expanded significantly during the late twentieth century as molecular biology techniques improved and researchers began mapping complex cellular signalling networks.

During this period, multiple peptides were identified that influence cellular communication, intracellular signalling and regulatory biochemical pathways.

Compounds such as BPC-157, KPV and Thymosin Beta-4 became subjects of laboratory investigation due to their involvement in peptide signalling systems.

Multi-peptide experimental formulations were subsequently developed to allow researchers to explore how different peptides interact within cellular regulatory pathways.

Mechanistic Focus in Research

Within experimental laboratory settings, Tri-Heal Max is often studied in relation to peptide-mediated cellular signalling systems.

Research investigations commonly explore the formulation in experimental models examining:

• Cellular repair signalling pathways
• Peptide interaction networks
• Regulatory signalling mechanisms
• Intracellular protein interaction pathways
• Cell migration signalling processes
• Comparative peptide pathway modelling
• Cellular regulatory network analysis

These experimental models allow scientists to investigate molecular mechanisms involved in cellular signalling and peptide-mediated regulatory processes.

Research Applications

In controlled research environments, Tri-Heal Max may be utilised in experimental models designed to explore peptide-mediated cellular signalling and regulatory networks.

Examples of research applications include:

• Cell signalling pathway investigation
• Peptide interaction research
• Intracellular regulatory network modelling
• Comparative peptide compound studies
• Molecular signalling pathway analysis
• Peptide regulatory mechanism research
• Controlled in vitro cellular signalling studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity multi-peptide research blend
Validated assay content BPC-157, KPV and TB-500
Retention time identification and full COA traceability
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.